24 May 2013
Keywords: clodronate, may, role, breast, cancer, treatment, roche
Article | 06 August 1998
Roche's acquisition of Corange may have brought it a hidden gem in theform of Boehringer Mannheim's bisphosphonate drug clodronate, if ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 1998
5 August 1998
4 August 1998
© 2013 thepharmaletter.com